Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma

Conditions:   First Line Chemotherapy;   Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel;   Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Intervention:   Drug: Capecitabine plus cisplatin(XP) versus capecitabine plus paclitaxel(XT)
Sponsor:   Samsung Medical Center
Recruiting - verified April 2017

http://ift.tt/2qfSFSv